SCHEMBL6462741

SCHEMBL6462741

O=C(O)NCC(C(=O)NCC(O)(CCc1ccccc1)c1nc2ccccc2o1)S(=O)(=O)Cc1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.36
CES1 P23141 1/20 0.36
DAGLA Q9Y4D2 1/20 0.36
ALDH1A1 P00352 1/20 0.35
MAPT P10636 5/20 0.35
LMNA P02545 3/20 0.35
PTPN2 P17706 4/20 0.33
PTPN1 P18031 4/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
XDH P47989 1/20 0.33
MEN1 O00255 1/20 0.32
TSHR P16473 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7049542 0.89 MAPT (0.40) ALDH1A1MAPTLMNAPTPN2PTPN1
SCHEMBL7046906 0.87 MAPT (0.43) ALDH1A1MAPTLMNACYP1A2CYP3A4
SCHEMBL6462894 0.87 MEN1 (0.38) ALDH1A1MAPTLMNAMEN1KMT2A
SCHEMBL6063046 0.86 LMNA (0.36) LMNAMEN1KMT2A
SCHEMBL6063233 0.83 FAAH (0.37) FAAHCES1DAGLAALDH1A1MAPT
SCHEMBL6462136 0.83 FAAH (0.37) FAAHCES1DAGLAALDH1A1MAPT
Hydrochloric Acid SCHEMBL6465937 0.82 FAAH (0.35) FAAHCES1DAGLAALDH1A1MAPT
SCHEMBL6467037 0.81 FAAH (0.36) FAAHCES1DAGLAALDH1A1MAPT
SCHEMBL6466282 0.81 LMNA (0.39) FAAHCES1DAGLAMAPTLMNA
SCHEMBL6061831 0.80 RAB9A (0.34) MAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1516877-A1 Amine derivatives as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-03-23 EP disclosed
US-6576630-B1 Alkanoyl substituted benzooxazoles or naphthooxazoles AXYS PHARMACEUTICALS, INC. 2003-06-10 US disclosed